Research and Markets (http://www.researchandmarkets.com/research/rdpj9s/continuous)
has announced the addition of the "Continuous
Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and
Adoption by Age Group) - Current Trends, Size, Share, Industry Analysis,
Competitive Intelligence, Growth, Opportunities and Global Forecasts,
2012 - 2020" report to their offering.
The global continuous glucose monitors market generated
revenue of $194.8 million in 2012 and is expected to reach market size
of value $568.5 million by 2020, growing at a CAGR of 14.8% during
This growth is attributed to increase in technological innovations,
namely launch of artificial pancreas, convenience offered by CGM over
self monitoring glucose devices, and earlier detection of the hypo &
hyperglycemic events by CGM.
Global CGM market is segmented based on application as home settings,
diagnostics and hospitals. Among all the application segments home
settings is expected to generate maximum revenue by 2020.
North Ameica is the maximum revenue-generating segment across the
globe, mainly due to rapid acceptance of innovative technology,
well-penetrated reimbursement system when compared with other
geographies and rise in patient pool. Asia Pacific is expected to grow
at a faster rate due to large patient pool, geographical expansion of
market players, increase in income levels and improved living standards
of the people.
Key market players in this market include: Medtronics, Dexcom, Animas
Corporation, Ypsomed AG, Omnipod and Miraculins, Inc., including others.
The major strategy adopted by the market players across this geography
is collaborations, product launches and approvals. Collaborations
specifically focus on distribution and commercialization of the devices.
- The report ranks the factors that are responsible for accelerating the
market growth driven by upper hand of CGM over self monitoring glucose
devices, approval for artificial pancreas and many more
- Market is forecasted for period of seven years 2013 to 2020 with
market revenues for 2 historic years of 2011 and 2012
- Identification and analysis of key pockets of investment for CGM
- Identification of challenges that must be addressed and overcome in
the CGM market to achieve fiscal success throughout the market
- Analysis of regulatory framework that regulates introduction of new
CGM and puts light on reimbursement scenario
- The report identifies and profiles key market participants that would
drive innovation in the CGM market
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Global Continuous Glucose Monitors Market Overview
Chapter 4 Continuous Glucose Monitoring Systems Market - By Devices
Chapter 5 Continuous Glucose Monitoring System Market - By Application
Chapter 6 Continuous Glucose Monitoring System Market - By Age
Chapter 7 CGM Systems Market By Geography
Chapter 8 Company Profiles
- Animas Corporation
- Dexcom Inc.
- Insulet Corporation
- Medtronic Inc.
- Novo Nordisk
- Spring Health Solution Ltd.
- Ypsomed AG
For more information visit http://www.researchandmarkets.com/research/rdpj9s/continuous.
[ Back To NFVZone's Homepage ]